Third Point Sparks Advance Auto Parts Rally

Advance Auto Parts Deal with Third Point, Moderna's Cancer Vaccine Trial, Chinese Tech Stocks Surge

After-hours Stock Action

Advance Auto Parts (AAP): Activist Agreement Boosts Stock

• Third Point Deal: Reached an agreement with activist Third Point for three board seats, leading to a slight rise in the extended session.
• Performance Gap: Significantly underperformed rivals like O’Reilly Automotive and AutoZone, down 40% in the last twelve months and 70% from its 2022 all-time high.

Moderna (MRNA): Rally on Cancer Vaccine Trial Hopes

• Positive Trial Outlook: Soared on optimism around a new cancer vaccine trial with Merck amid declining demand for Covid products.
• Analyst Sentiment: Most analysts have a buy rating on the stock; finished session 15% below average price target.

Chinese Tech Stocks: Mixed Bag of Performances

• Bilibili (BILI) & JD.com (JD): Notable movers post-earnings gains and analyst upgrades; up about 22% and roughly 19% respectively in a week.
• PDD Holdings (PDD): Dueling analyst notes led to mixed performance; down 8% in a week and lower year-to-date compared to other Chinese tech giants.

Vail Resorts (MTN): Snowfall Woes Impact Earnings

• Disappointing Results: Weak performance due to low snowfall and variable temperatures at North American locations.
• Guidance Cut: Cutting guidance due to weak season performance; stock remains flat over the past twelve months and is off by 40% from its 2021 high.